β-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1β- and tumor necrosis factor-α (TNFα)-dependent, and involves a TNFα receptor-associated factor- and NFκB-inducing kinase-dependent signaling mechanism

被引:308
作者
Akama, KT
Van Eldik, LJ
机构
[1] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA
[2] Northwestern Univ, Sch Med, Northwestern Drug Discovery Program, Chicago, IL 60611 USA
关键词
D O I
10.1074/jbc.275.11.7918
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In Alzheimer's disease, beta-amyloid (AP) plaques are surrounded by activated astrocytes and microglia, A growing body of evidence suggests that these activated glia contribute to neurotoxicity through the induction of inflammatory cytokines such as interleukin (IL)-1 beta and tumor necrosis factor-ac (TNF alpha) and the production of neurotoxic free radicals, mediated in part by the expression of inducible nitric-oxide synthase (iNOS). Here, we address the possibility that A beta-stimulated iNOS expression might result from an initial induction of IL-1 beta and TNF alpha. We find that in A beta-stimulated astrocyte cultures, IL-1 beta and TNF alpha production occur before iNOS production, new protein synthesis is required for increased iNOS mRNA levels, and the IL-I receptor antagonist IL-1 beta can inhibit nitrite accumulation. Likewise, dominant-negative mutants of tumor necrosis factor-alpha receptor-associated factor (TRAF) 6, TRAF2, and NF kappa B-inducing kinase (NIK), intracellular proteins involved in IL-I and TNF alpha! receptor signaling cascades, inhibit A beta-stimulated iNOS promoter activity. Our data suggest that A beta stimulation of astrocyte iNOS is mediated in part by IL-1 beta and TNF alpha, and involves a TRAFG-, TRAF2-, and NIK-dependent signaling mechanism.
引用
收藏
页码:7918 / 7924
页数:7
相关论文
共 60 条
[21]   Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury [J].
Friedlander, RM ;
Gagliardini, V ;
Hara, H ;
Fink, KB ;
Li, WW ;
MacDonald, G ;
Fishman, MC ;
Greenberg, AH ;
Moskowitz, MA ;
Yuan, JY .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (05) :933-940
[22]   Molecular biology of nitric oxide synthases [J].
Geller, DA ;
Billiar, TR .
CANCER AND METASTASIS REVIEWS, 1998, 17 (01) :7-23
[23]  
GRIFFIN WST, 1993, ALTSCHUL SY, V2, P359
[24]  
Griffin WST, 1998, BRAIN PATHOL, V8, P65
[25]   p38 kinase is activated in the Alzheimer's disease brain [J].
Hensley, K ;
Floyd, RA ;
Zheng, NY ;
Nael, R ;
Robinson, KA ;
Nguyen, X ;
Pye, QN ;
Stewart, CA ;
Geddes, J ;
Markesbery, WR ;
Patel, E ;
Johnson, GVW ;
Bing, GY .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (05) :2053-2058
[26]   Amyloid-β peptide activates cultured astrocytes:: morphological alterations, cytokine induction and nitric oxide release [J].
Hu, JG ;
Akama, KT ;
Krafft, GA ;
Chromy, BA ;
Van Eldik, LJ .
BRAIN RESEARCH, 1998, 785 (02) :195-206
[27]  
Hu JR, 1997, J NEUROCHEM, V69, P2294
[28]  
Iadecola C, 1997, J NEUROSCI, V17, P9157
[29]   Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region [J].
Ishida, T ;
Mizushima, S ;
Azuma, S ;
Kobayashi, N ;
Tojo, T ;
Suzuki, K ;
Aizawa, S ;
Watanabe, T ;
Mosialos, G ;
Kieff, E ;
Yamamoto, T ;
Inoue, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :28745-28748
[30]  
Jobin C, 1999, J IMMUNOL, V162, P4447